US2020188339A1PendingUtilityA1
Nutraceutical Composition Comprising C60 And Ketone Esters
Est. expiryDec 14, 2038(~12.4 yrs left)· nominal 20-yr term from priority
Inventors:Max C. Champie
A23L 33/10A23L 33/00A61K 36/71A61K 36/28A61K 31/122A61K 31/194A61K 47/44A61K 31/192
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
An anti-oxidative, energy-boosting, and anti-aging nutraceutical composition containing fullerene substituted with functional groups, a medium chain triglyceride (preferably black seed oil), and the composition optionally includes one or more energy molecules not bound to the fullerene. Preferred functional groups and energy molecules include beta-hydroxybutyrate (more preferably D-beta-hydroxybutyrate) and carboxylic acids (e.g., caprylic acid and/or capric acid).
Claims
exact text as granted — not AI-modified1 . A nutraceutical composition, comprising a fullerene molecule substituted with a beta-hydroxybutyrate group.
2 . The nutraceutical composition in claim 1 , wherein the beta-hydroxybutyrate group is D-beta-hydroxybutyrate.
3 . The nutraceutical composition in claim 1 , wherein the substituted fullerene molecule is further substituted with a carboxylic acid.
4 . The nutraceutical composition in claim 3 , wherein the carboxylic acid is caprylic acid.
5 . The nutraceutical composition in claim 3 , wherein the carboxylic acid is capric acid
6 . The nutraceutical composition in claim 1 , wherein the substituted fullerene molecule is further substituted with two different carboxylic acids.
7 . The nutraceutical composition in claim 6 , wherein the two carboxylic acids are caprylic acid and capric acid.
8 . The nutraceutical composition in claim 1 , wherein the fullerene molecule is C60.
9 . The nutraceutical composition in claim 1 , further comprising a medium chain triglyceride.
10 . The nutraceutical composition in claim 9 , further comprising a COX-2 inhibitor.
11 . The nutraceutical composition in claim 10 , wherein the COX-2 inhibitor is thymoquinone.
12 . The nutraceutical composition in claim 1 , further comprising black seed oil.
13 . The nutraceutical composition in claim 12 , further comprising sunflower seed oil.
14 . The nutraceutical composition in claim 12 , further comprising lecithin.
15 . The nutraceutical composition in claim 12 , further comprising beta-hydroxybutyrate molecules not bound to the fullerene molecule.
16 . The nutraceutical composition in claim 15 , further comprising carboxylic acid molecules not bound to the fullerene molecule.
17 . The nutraceutical composition in claim 16 , wherein the carboxylic acid molecules are caprylic acid molecules.
18 . The nutraceutical composition in claim 16 , wherein the carboxylic acid molecules are capric acid molecules.
19 . The nutraceutical composition in claim 15 , further comprising two different carboxylic acids not bound to the fullerene molecule.
20 . The nutraceutical composition in claim 19 , wherein the two carboxylic acids are caprylic acid and capric acid.
21 . The nutraceutical composition in claim 8 , wherein C60 is saturated with substituted beta-hydroxybutyrate groups.
22 . The nutraceutical composition in claim 8 , wherein the beta-hydroxybutyrate group is D-beta-hydroxybutyrate.
23 . The nutraceutical composition in claim 8 , wherein C60 is further substituted with a carboxylic acid.
24 . The nutraceutical composition in claim 23 , wherein the carboxylic acid is caprylic acid.
25 . The nutraceutical composition in claim 23 , wherein the carboxylic acid is capric acid
26 . The nutraceutical composition in claim 8 , wherein C60 is substituted with two different carboxylic acids.
27 . The nutraceutical composition in claim 26 , wherein the two carboxylic acids are caprylic acid and capric acid.
28 . The nutraceutical composition in claim 8 , further comprising a medium chain triglyceride.
29 . The nutraceutical composition in claim 8 , further comprising black seed oil.
30 . The nutraceutical composition in claim 8 , further comprising beta-hydroxybutyrate molecules not bound to C60.
31 . The nutraceutical composition in claim 8 , further comprising carboxylic acid molecules not bound to C60.
32 . The nutraceutical composition in claim 31 , wherein the carboxylic acid molecules are caprylic acid molecules.
33 . The nutraceutical composition in claim 31 , wherein the carboxylic acid molecules are capric acid molecules.
34 . The nutraceutical composition in claim 8 , further comprising two different carboxylic acids not bound to C60.
35 . The nutraceutical composition in claim 34 , wherein the two carboxylic acids are caprylic acid and capric acid.
36 . The nutraceutical composition in claim 8 , further comprising thymoquinone.
37 . The nutraceutical composition in claim 8 , wherein the beta-hydroxybutyrate group is on a surface of C60.
38 . The nutraceutical composition in claim 8 , wherein the beta-hydroxybutyrate group is on an outside surface of C60.
39 . The nutraceutical composition in claim 8 , further comprising a COX-2 inhibitor.Join the waitlist — get patent alerts
Track US2020188339A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.